Evrys Bio - Crunchbase Company Profile & Funding

Q: Who invested in Evrys Bio?

Evrys Bio has 4 investors including Defense Threat Reduction Agency (DTRA) And Keiretsu Capital.

Q: When was the last funding round for Evrys Bio?

Evrys Bio closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Evrys Bio raised to date?

Evrys Bio has raised obfuscated.

Overview

Evrys Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Evrys Bio

CB Rank

28749

Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.

Founded

obfuscation

Private

Grant

Doylestown, Pennsylvania, United States

1-10

evrysbio.com

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Thomas E. Shenk: Founder
Lillian Chiang: CEO, Co-Founder & President

Details

Legal Name

Evrys Bio, LLC

Also Known As

Forge Life Science

Operating Status

Active

Company Type

For Profit

Founders

Ileana Cristea, Lillian Chiang, Thomas E. Shenk

About the Company

Evrys Bio was founded on breakthrough discoveries made at Princeton University. Whereas immuno-oncology drugs engage the patient’s immune system to fight cancer, Evrys Bio antivirals engage the cell’s intrinsic immunity to defend against infection. Evrys Bio’s vision is to develop first-in-class antivirals that are safe, address the problem of

acquired drug-resistance, and provide unique broad-spectrum treatment options. This will transform the practice of medicine by addressing the infectious disease condition holistically as opposed to targeting a specific virus-type.

Phone Number

609-874-9013

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Broad Spectrum Antivirals

Evrys Bio's antivirals target human proteins called sirtuins to enhance their natural ability to fight infections, addressing multiple viruses that cause a given infectious disease.

Pan-Respiratory Infections Antiviral

An antiviral for treating respiratory infections, effective against coronaviruses, respiratory syncytial virus, adenoviruses, and influenza A and B strains.

Research & Development

Evrys Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant
obfuscated obfuscation	Grant - Evrys Bio	1	obfuscated obfuscation	Defense Threat Reduction Agency (DTRA)	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Defense Threat Reduction Agency (DTRA)	Yes	Grant - Evrys Bio	—
Defense Threat Reduction Agency (DTRA)	Yes	Grant - Evrys Bio	—
Defense Threat Reduction Agency (DTRA)	Yes	Grant - Evrys Bio	—
Defense Threat Reduction Agency (DTRA)	Yes	Grant - Evrys Bio	—
Defense Threat Reduction Agency (DTRA)	Yes	Grant - Evrys Bio	—